Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

131.02 -1.96 (-1.47%)
Official Closing Price Updated: 7:59 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Moderna Inc

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Thinking about trading stocks or options in Twilio, Moderna, Walt Disney, Electronic Arts, or Ford?
InvestorsObserver issues critical PriceWatch Alerts for TWLO, MRNA, DIS, EA, and F. 
From PR Newswire
Moderna Reports First Quarter 2020 Financial Results and Provides Business Updates
Moderna reports first quarter 2020 financial results and provides business updates. 
From Business Wire News Releases
Growing Number of Collaborations In U.S. Public & Private Sectors Fueling Positive Coronavirus Vaccine Developments
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Growing Number of Collaborations in U.S. Public & Private Sectors Fueling Positive Coronavirus Vaccine Developments
Financialnewsmedia.com News Commentary 
From PR Newswire
Thinking about trading stocks or options in Apple, Moderna, Ford, Spirit Airlines, or Netflix?
InvestorsObserver issues critical PriceWatch Alerts for AAPL, MRNA, F, SAVE, and NFLX. 
From PR Newswire
Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine (mRNA-1273) Against Novel Coronavirus
Moderna and Lonza announce worldwide strategic collaboration to manufacture Moderna’s vaccine (mRNA-1273) against novel coronavirus. 
From Business Wire News Releases
Thinking about trading stocks or options in Arcturus Therapeutics, Laboratory Corp. of America, Bed Bath & Beyond, Moderna, or Zillow?
InvestorsObserver issues critical PriceWatch Alerts for ARCT, LH, BBBY, MRNA, and Z. 
From PR Newswire
Moderna Announces IND Submitted to U.S. FDA for Phase 2 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
Moderna announces IND submitted to U.S. FDA for Phase 2 study of mRNA vaccine (mRNA-1273) against novel coronavirus. 
From Business Wire News Releases
Moderna to Report First Quarter 2020 Financial Results on Thursday, May 7th, 2020
Moderna to report first quarter 2020 financial results on Thursday, May 7th, 2020. 
From Business Wire News Releases
Scientists Gaining Hope for Finding COVID-19 Vaccine Faster Than Expected
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Scientists Gaining Hope for Finding COVID-19 Vaccine Faster Than Expected
Financialnewsmedia.com News Commentary 
From PR Newswire
Thinking about trading options or stock in Beyond Meat, Walt Disney, Lockheed Martin, Moderna, or Tesla?
InvestorsObserver issues critical PriceWatch Alerts for BYND, DIS, LMT, MRNA, and TSLA. 
From PR Newswire
Clinical Trials for COVID-19 Treatments or Vaccines Reaching Unprecedented Levels
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Clinical Trials for COVID-19 Treatments or Vaccines Reaching Unprecedented Levels
Financialnewsmedia.com News Commentary 
From PR Newswire
Moderna Announces Award from U.S. Government Agency BARDA for up to $483 Million to Accelerate Development of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
Moderna announces award from BARDA for up to $483 million to accelerate development of mRNA vaccine (mRNA-1273) against novel coronavirus. 
From Business Wire News Releases
Companies Rush to Develop Innovative Viral Medicines
FinancialBuzz.com News Commentary 
From PR Newswire
Thinking about buying stock in Aytu Bioscience, Boeing, Canopy Growth Corp, Moderna, or Rite Aid?
InvestorsObserver issues critical PriceWatch Alerts for AYTU, BA, CGC, MRNA, and RAD. 
From PR Newswire
Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response
Deal is part of Ginkgo's $25 million commitment to make its biological discovery and production services available to firms working on diagnostics, treatments, and vaccines in response to COVID-19 
From PR Newswire
Growing Number of Coronavirus Vaccines Under Development With 3 in Human Trials
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Growing Number of Coronavirus Vaccines Under Development With 3 in Human Trials
Financialnewsmedia.com News Commentary 
From PR Newswire
Moderna Highlights Opportunity of mRNA Vaccines at its First Vaccines Day
Moderna highlights opportunity of mRNA vaccines at its first Vaccines Day. 
From Business Wire News Releases
Moderna Announces that Its 2020 Annual Meeting of Stockholders Will be Held in Virtual Format
Moderna, Inc. announces that Its 2020 Annual Meeting of Stockholders will be held in virtual format. 
From Business Wire News Releases
Moderna to Present at 19th Annual Needham Healthcare Conference
Moderna to present at 19th Annual Needham Healthcare Conference. 
From Business Wire News Releases
FDA Accelerates Development of Novel Therapies for COVID-19
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
FDA Accelerates Development of Novel Therapies for COVID-19
Financialnewsmedia.com News Commentary 
From PR Newswire
Moderna to Host Virtual Vaccines Day on April 14, 2020
Moderna to host virtual Vaccines Day on April 14, 2020. 
From Business Wire News Releases
The Threat of Infectious Diseases Impulses Governments and Businesses Towards Adjustments
FinancialBuzz.com News Commentary 
From PR Newswire
Flagship Pioneering Completes Raising a New $1.1 Billion Capital Pool
Fueling the Next Wave of Life Science Innovations and Pioneering Ventures 
From PR Newswire
Thinking about buying stock in Advanced Micro Devices, Aytu Bioscience, Inseego, Moderna, or SuperCom?
InvestorsObserver issues critical PriceWatch Alerts for AMD, AYTU, INSG, MRNA, and SPCB. 
From PR Newswire
Moderna Provides Update on the Impact of COVID-19 on Business Operations and Clinical Program Development
Moderna provides an update on the impact of COVID-19 on business operations and clinical program development. 
From Business Wire News Releases
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.